Venturi Wealth Management LLC Sells 137 Shares of Humana Inc. (NYSE:HUM)

Venturi Wealth Management LLC reduced its stake in shares of Humana Inc. (NYSE:HUM) by 59.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 95 shares of the insurance provider’s stock after selling 137 shares during the quarter. Venturi Wealth Management LLC’s holdings in Humana were worth $30,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in HUM. Creative Financial Designs Inc. ADV increased its position in shares of Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. increased its position in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares during the last quarter. Atwood & Palmer Inc. purchased a new stake in shares of Humana in the third quarter valued at $29,000. Ashton Thomas Securities LLC bought a new stake in shares of Humana in the 3rd quarter worth about $31,000. Finally, Your Advocates Ltd. LLP boosted its stake in shares of Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have issued reports on HUM shares. Oppenheimer decreased their price objective on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research note on Thursday, October 3rd. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and boosted their price objective for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. KeyCorp began coverage on Humana in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Leerink Partners lowered shares of Humana from an “outperform” rating to a “market perform” rating and lowered their target price for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Finally, Piper Sandler downgraded shares of Humana from an “overweight” rating to a “neutral” rating and reduced their price target for the stock from $392.00 to $274.00 in a research note on Thursday, October 3rd. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $315.86.

Humana Trading Down 2.6 %

NYSE HUM opened at $275.67 on Friday. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $527.18. The company has a 50 day moving average price of $281.36 and a 200 day moving average price of $331.61. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm has a market cap of $33.19 billion, a PE ratio of 24.42, a price-to-earnings-growth ratio of 2.29 and a beta of 0.52.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, sell-side analysts forecast that Humana Inc. will post 15.83 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.28%. Humana’s payout ratio is 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.